Skip to main content
Clinical Trials/NCT04027699
NCT04027699
Completed
N/A

Predictive Mini-bolus Fluid Responsiveness in Pediatric Septic Shock

Assistance Publique - Hôpitaux de Paris1 site in 1 country11 target enrollmentFebruary 23, 2021

Overview

Phase
N/A
Intervention
Not specified
Conditions
Severe Sepsis or Septic Shock in Pediatric Intensive Care Unit
Sponsor
Assistance Publique - Hôpitaux de Paris
Enrollment
11
Locations
1
Primary Endpoint
Cardiac output variability (ΔCO)
Status
Completed
Last Updated
5 months ago

Overview

Brief Summary

Severe sepsis and septic shock remain of particular gravity in children with a current mortality of about 20 % , despite the international prevention campaigns " survival sepsis campaign ". Septic shock associates a macrocirculatory and a microcirculatory dysfunction. The volume expansion remains the treatment of severe sepsis at the initial phase supplemented by the use of vasopressors and / or inotropes. Nevertheless , it is essential to predict the fluid responsiveness after volemic expansion because fluid overload is associated with an increased morbidity in children. In studies , the volume expansion is considered effective if it allows an increase in cardiac output of more than 15 % compared to the basal level. However, their conditions of use remain very restrictive and not applicable to most of our patients ( tidal volume ≥ 7ml / kg , PEEP sufficient , absence of cardiac arrhythmia and effective sedation ) . To date , no index can be used for all patients with invasive mechanical ventilation.

It therefore seems appropriate to develop new tests to predict the response to volume expansion in children with septic shock hospitalized in pediatric intensive care.

A recent study has validated a test to predict the response to volume expansion in adults: injection of a mini-bolus of 50 ml of saline over 10s.

The aim of the study is to evaluate the effect of mini bolus fluid to predict response to fluid expansion in pediatric septic shock.

Detailed Description

Severe sepsis and septic shock remain of particular gravity in children with a current mortality of about 20 % , despite the international prevention campaigns " survival sepsis campaign " . Septic shock associates a macrocirculatory and a microcirculatory dysfunction. The volume expansion remains the treatment of severe sepsis at the initial phase supplemented by the use of vasopressors and / or inotropes . Nevertheless , it is essential to predict the fluid responsiveness after volemic expansion because fluid overload is associated with an increased morbidity in children . In studies , the volume expansion is considered effective if it allows an increase in cardiac output of more than 15 % compared to the basal level . However , their conditions of use remain very restrictive and not applicable to most of our patients ( tidal volume \> 7ml / kg , PEEP sufficient, absence of cardiac arrhythmia and effective sedation ) . To date , no index can be used for all patients with invasive mechanical ventilation . It therefore seems appropriate to develop new tests to predict the response to volume expansion in children with septic shock hospitalized in pediatric intensive care. A recent study has validated a test to predict the response to volume expansion in adults : injection of a mini-bolus of 50 ml of saline over 10s. The aim of the study is to evaluate the effect of mini bolus fluid to predict response to fluid expansion in pediatric septic shock.

Registry
clinicaltrials.gov
Start Date
February 23, 2021
End Date
February 20, 2023
Last Updated
5 months ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Baby (\>28 days) or children \< 15 years
  • Hospitalisation in paediatric intensive
  • Clinico-biological table compatible with severe sepsis or septic shock (likely or documented)
  • Requiring the use of invasive mechanical ventilation
  • Affiliate or beneficiary of a social security
  • Legal guardians Consent Form or Emergency Procedure

Exclusion Criteria

  • Any serious hemodynamic clinical situation that would be delayed by inclusion in the protocol
  • Patient with shunt heart disease
  • Patient in spontaneous or non-invasive ventilation or CPAP
  • Patient with a contraindication to volemic/fluid expansion (major cardiac dysfunction, acute renal failure)
  • Patient with cardiac arrest upper 5 min
  • Postcardiotomia

Outcomes

Primary Outcomes

Cardiac output variability (ΔCO)

Time Frame: 15 minutes

Cardiac output : ΔCO (mL/min) = VES (ml)\* heart rate and VES (cm3)= ITVA0(cm) \* SA0 (cm2)

Secondary Outcomes

  • Heart rate variation (ΔHR)(15 minutes)
  • Microvascular Flow Index variation (ΔMFI)(15 min)
  • Pulse pressure variation (ΔPP)(15 minutes)
  • Velocity time-index variation (ΔVTI)(15 minutes)
  • Systolic ejection volume variation (ΔSEV)(15 minutes)
  • Systolic, diastolic and mean arterial pressure variation (ΔSAP, ΔDAP, ΔMAP)(15 minutes)
  • Proportion Perfused Vessels variation (ΔPPV)(5 minutes)

Study Sites (1)

Loading locations...

Similar Trials